封面
市場調查報告書
商品編碼
1468336

2024-2032 年經導管主動脈瓣植入市場(依手術、最終使用者和地區分類)

Transcatheter Aortic Valve Implantation Market by Procedure, End User, and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2023年全球經導管主動脈瓣植入術(TAVI)IMARC Group規模達63億美元。 10.65% 。冠狀動脈疾病的盛行率不斷上升、微創療法的日益普及以及老年人口的不斷擴大是推動市場發展的一些關鍵因素。

經導管主動脈瓣植入術(TAVI) 是一種用於治療主動脈瓣狹窄的微創外科手術,主動脈瓣狹窄是一種心臟疾病,主動脈瓣變窄,導致從心臟到身體其他部位的血流量減少。在手術過程中,會在患者的腹股溝或胸部切一個小切口。插入導管並引導其穿過股動脈或主動脈到達狹窄的主動脈瓣。由生物材料(例如動物組織或合成材料)製成的人工瓣膜會透過導管展開並定位在狹窄的瓣膜內,該瓣膜會膨脹以取代舊的瓣膜,使血液能夠從心臟自由流動。 TAVI 可在局部麻醉下進行。與傳統手術相比,它的恢復時間更短,併發症風險更低,適合因病重或虛弱而無法進行心臟直視手術的患者。

經導管主動脈瓣植入 (TAVI) 市場趨勢:

越來越多的患者患有心臟衰竭、高血壓、冠狀動脈疾病和心血管疾病(CVD),特別是主動脈瓣狹窄,這主要推動了經導管主動脈瓣植入(TAVI)市場的成長。除此之外,由於微創手術(MIS) 具有減少住院時間、縮短復健時間、改善結果和降低整體醫療保健支出等優勢,消費者對微創手術(MIS) 的偏好相對於傳統心臟直視手術的轉變正在創造積極的前景。此外,消費者對主動脈瓣疾病和可用治療方案的認知不斷提高,從而實現早期診斷和及時治療,這有助於市場成長。除此之外,研發 (R&D) 計畫的大量資金以及 TAVI 手術中持續的技術進步(例如生物瓣膜、自膨脹瓣膜和其他創新設備的開發)正在加強市場成長。此外,醫療保健產業的強勁成長、臨床試驗數量的增加、產品的持續創新、老年人口的不斷擴大以及有利的報銷政策都為市場帶來了豐厚的成長機會。

本報告回答的關鍵問題

  • 全球經導管主動脈瓣植入術(TAVI)市場有多大?
  • 2024-2032年全球經導管主動脈瓣植入術(TAVI)市場的預期成長率為何?
  • 推動全球經導管主動脈瓣植入(TAVI)市場的關鍵因素是什麼?
  • COVID-19 對全球經導管主動脈瓣植入 (TAVI) 市場有何影響?
  • 根據此手術,全球經導管主動脈瓣植入 (TAVI) 市場的細分如何?
  • 基於最終用戶的全球經導管主動脈瓣植入 (TAVI) 市場的詳細情形如何?
  • 全球經導管主動脈瓣植入術(TAVI)市場的關鍵地區有哪些?
  • 全球經導管主動脈瓣植入 (TAVI) 市場的主要參與者/公司有哪些?

目錄

第1章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球經導管主動脈瓣植入 (TAVI) 市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章:市場區隔:依程序

  • 經股手術
    • 市場走向
    • 市場預測
  • 經心尖植入
    • 市場走向
    • 市場預測
  • 經主動脈植入
    • 市場走向
    • 市場預測

第 7 章:市場區隔:按最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 診斷實驗室
    • 市場走向
    • 市場預測
  • 門診手術中心
    • 市場走向
    • 市場預測
  • 診所
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章:市場區隔:按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分:按國家/地區
    • 市場預測

第 9 章:促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 10 章:價值鏈分析

第 11 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章:價格分析

第13章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation
    • JC Medical Inc. (Genesis Medtech International Private Limited)
    • Medtronic plc
    • Meril Life Sciences Pvt. Ltd.
    • NVT AG (Biosensors International Group)
    • Venus Medtech (Hangzhou) Inc.
Product Code: SR112024A7501

The global transcatheter aortic valve implantation (TAVI) market size reached US$ 6.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.1 Billion by 2032, exhibiting a growth rate (CAGR) of 10.65% during 2024-2032. The increasing prevalence of coronary artery disease, the rising adoption of minimally invasive therapies, and the expanding geriatric population represent some of the key factors driving the market.

Transcatheter Aortic Valve Implantation (TAVI) refers to a minimally invasive surgical procedure used to treat aortic stenosis, a heart condition in which the aortic valve narrows, resulting in reduced blood flow from the heart to the rest of the body. During the procedure, a small incision is made in the patient's groin or chest. A catheter is inserted and guided through the femoral artery or the aorta to the narrowed aortic valve. An artificial valve made of biological material, such as animal tissue or synthetic materials, is deployed through the catheter and positioned inside the narrowed valve, which expands to replace the old valve, allowing blood to flow freely from the heart. TAVI can be performed under local anesthesia. Compared to traditional surgery, it has a shorter recovery time and a lower risk of complications and can be performed on patients who are too ill or frail to undergo open-heart surgery.

Transcatheter Aortic Valve Implantation (TAVI) Market Trends:

The growing number of patients suffering from heart failure, hypertension, coronary artery disease, and cardiovascular diseases (CVDs), particularly aortic stenosis, is primarily driving the transcatheter aortic valve implantation (TAVI) market growth. Besides this, the shifting consumer preference for minimally invasive surgery (MIS) over conventional open-heart surgery due to its advantages, such as reduced hospital stay, shorter recovery time, improved outcomes, and lower overall healthcare spending, is creating a positive outlook for the market. Moreover, the escalating consumer awareness about aortic valve disease and available treatment options leading to early diagnosis and timely treatment is contributing to the market growth. In addition to this, the extensive funding in research and development (R&D) initiatives and ongoing technological advancements in the TAVI procedure, such as the development of bioprosthetic valves, self-expanding valves, and other innovative devices, are strengthening the market growth. Furthermore, the bolstering growth of the healthcare industry, the increasing number of clinical trials, continuous product innovations, the expanding geriatric population, and favorable reimbursement policies are presenting remunerative growth opportunities for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global transcatheter aortic valve implantation (TAVI) market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on procedure and end user.

Procedure Insights:

Transfemoral Procedure

Transapical Implantation

Transaortic Implantation

The report has provided a detailed breakup and analysis of the transcatheter aortic valve implantation (TAVI) market based on the procedure. This includes the transfemoral procedure, transapical implantation, and transaortic implantation. According to the report, transfemoral procedure represented the largest segment.

End User Insights:

Hospitals

Diagnostic Labs

Ambulatory Surgical Centers

Clinics

Others

A detailed breakup and analysis of the transcatheter aortic valve implantation (TAVI) market based on the end user has also been provided in the report. This includes hospitals, diagnostic labs, ambulatory surgical centers, clinics, and others. According to the report, hospitals accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for transcatheter aortic valve implantation (TAVI). Some of the factors driving the North America transcatheter aortic valve implantation (TAVI) market included the expanding prevalence of cardiovascular diseases, the rising adoption of minimally invasive therapies, and ongoing technological advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global transcatheter aortic valve implantation (TAVI) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, JC Medical Inc. (Genesis Medtech International Private Limited), Medtronic plc, Meril Life Sciences Pvt. Ltd., NVT AG (Biosensors International Group), Venus Medtech (Hangzhou) Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 2. What is the expected growth rate of the global Transcatheter Aortic Valve Implantation (TAVI) market during 2024-2032?
  • 3. What are the key factors driving the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 4. What has been the impact of COVID-19 on the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 5. What is the breakup of the global Transcatheter Aortic Valve Implantation (TAVI) market based on the procedure?
  • 6. What is the breakup of the global Transcatheter Aortic Valve Implantation (TAVI) market based on the end user?
  • 7. What are the key regions in the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 8. Who are the key players/companies in the global Transcatheter Aortic Valve Implantation (TAVI) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transcatheter Aortic Valve Implantation (TAVI) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Procedure

  • 6.1 Transfemoral Procedure
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Transapical Implantation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Transaortic Implantation
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Labs
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ambulatory Surgical Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Clinics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Boston Scientific Corporation
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Edwards Lifesciences Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 JC Medical Inc. (Genesis Medtech International Private Limited)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Medtronic plc
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Meril Life Sciences Pvt. Ltd.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 NVT AG (Biosensors International Group)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Venus Medtech (Hangzhou) Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Transcatheter Aortic Valve Implantation Market: Major Drivers and Challenges
  • Figure 2: Global: Transcatheter Aortic Valve Implantation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Transcatheter Aortic Valve Implantation Market: Breakup by Procedure (in %), 2023
  • Figure 5: Global: Transcatheter Aortic Valve Implantation Market: Breakup by End User (in %), 2023
  • Figure 6: Global: Transcatheter Aortic Valve Implantation Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Transcatheter Aortic Valve Implantation (Transfemoral Procedure) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Transcatheter Aortic Valve Implantation (Transfemoral Procedure) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Transcatheter Aortic Valve Implantation (Transapical Implantation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Transcatheter Aortic Valve Implantation (Transapical Implantation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Transcatheter Aortic Valve Implantation (Transaortic Implantation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Transcatheter Aortic Valve Implantation (Transaortic Implantation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Transcatheter Aortic Valve Implantation (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Transcatheter Aortic Valve Implantation (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Transcatheter Aortic Valve Implantation (Diagnostic Labs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Transcatheter Aortic Valve Implantation (Diagnostic Labs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Transcatheter Aortic Valve Implantation (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Transcatheter Aortic Valve Implantation (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Transcatheter Aortic Valve Implantation (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Transcatheter Aortic Valve Implantation (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Transcatheter Aortic Valve Implantation (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Transcatheter Aortic Valve Implantation (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: North America: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: North America: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: United States: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: United States: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Canada: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Canada: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Asia-Pacific: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Asia-Pacific: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: China: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: China: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Japan: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Japan: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: India: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: India: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: South Korea: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: South Korea: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Australia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Australia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Indonesia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Indonesia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Europe: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Europe: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Germany: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Germany: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: France: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: France: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: United Kingdom: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: United Kingdom: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Italy: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Italy: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Spain: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Spain: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Russia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Russia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Latin America: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Latin America: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Brazil: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Brazil: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Mexico: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Mexico: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Middle East and Africa: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Middle East and Africa: Transcatheter Aortic Valve Implantation Market: Breakup by Country (in %), 2023
  • Figure 71: Middle East and Africa: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Global: Transcatheter Aortic Valve Implantation Industry: Drivers, Restraints, and Opportunities
  • Figure 73: Global: Transcatheter Aortic Valve Implantation Industry: Value Chain Analysis
  • Figure 74: Global: Transcatheter Aortic Valve Implantation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transcatheter Aortic Valve Implantation Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by Procedure (in Million US$), 2024-2032
  • Table 3: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 4: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Transcatheter Aortic Valve Implantation Market: Competitive Structure
  • Table 6: Global: Transcatheter Aortic Valve Implantation Market: Key Players